CEACAM5 and cancer: Approximately 5% of subjects without cancer had elevated CYFRA 21 − 1 levels once in five tests over four years, while 15% had elevated CYFRA 21 − 1 levels once or more, which was > 10-fold higher than the rate for CEA (1.2%).